Open AccessOlanzapine-high potency antipsychotic drug inducing significant weight gain: A case report
Author(s) -
Nadja P. Marić,
Dragana Josifović-Kostić,
Olivera Vuković,
Dubravka Britivić,
Miroslava Jašović-Gašić
Publication year - 2008
Publication title -
srpski arhiv za celokupno lekarstvo
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.135
H-Index - 17
eISSN - 2406-0895
pISSN - 0370-8179
DOI - 10.2298/sarh0806284m
Subject(s) - olanzapine , medicine , weight gain , risperidone , clozapine , antipsychotic , haloperidol , schizophrenia (object oriented programming) , atypical antipsychotic , psychiatry , body weight , dopamine
Olanzapine is a second generation antipsychotic (SGA) with a high level of therapeutic effectiveness in schizophrenia and other psychotic disorders. Along with the positive therapeutic effects, an increase of the body weight frequently occurs. According to the literature, the average weight gain is about 6-7 kg during several months of treatment. This could be valued as a moderate weight increase.